Market Place
Sourcing Support
All News #Library
Others
Currax Expands Obesity Treatment Access via PeekDirect™
01 Apr 2026 //
PR NEWSWIRE
Joint TOS/OMA/OAC Ranks Contrave Top in U.S. Obesity Management
25 Mar 2026 //
PR NEWSWIRE
Currax Shows CONTRAVE Data at ObesityWeek on Cravings Control
04 Nov 2025 //
PR NEWSWIRE
Currax Pharma Showcases CONTRAVE Research At Obesityweek 2025
28 Oct 2025 //
PR NEWSWIRE
Currax to Offer CONTRAVE Free to Federal Staff During Shutdown
23 Oct 2025 //
PR NEWSWIRE
Currax Offers FDA-Approved Obesity Drug Contrave at Cash Price
15 Jul 2025 //
PR NEWSWIRE
Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety
11 Mar 2025 //
PR NEWSWIRE
Currax Announces Outstanding 2024 Financial & Performance
10 Jan 2025 //
PR NEWSWIRE
Currax Launches First CONTRAVE® TV Ad & "Cravings Don`t Own Me"
02 Jan 2025 //
PR NEWSWIRE
Currax: CONTRAVE®/MYSIMBA® demonstrates no increased risk in cardiac events
18 Oct 2023 //
PR NEWSWIRE
Currax Files Lawsuit Against Found Health for False Marketing of CONTRAVE
06 Mar 2023 //
PR NEWSWIRE
Currax Launches New Campaign to Address Emotional Eating Challenges
29 Aug 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.